查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363318

核酸增幅檢查市場規模、佔有率、趨勢分析報告：按類型、用途、最終用途、地區和細分市場預測，2023-2030

Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Type (PCR, INAAT), By Application (Infectious Disease Testing, Oncology Testing), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

核酸增幅檢查市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球核酸增幅檢查市場規模將達192億美元，2023年至2030年年複合成長率為12.2%。

人們對慢性病和感染疾病早期檢測的認知不斷提高，以及 PCR 技術的新技術進步，要素將顯著推動市場成長。此外，全球範圍內流感、肝炎和性行為感染等感染疾病的日益流行預計將增加對核酸增幅檢查的需求並對市場成長產生積極影響。

近年來，核酸增幅檢查吸引了大量投資，因為它們適用於診斷各種病理，包括癌症等危及生命的病理。津貼，公共投資的美國基因的開發。

此外，核酸增幅檢查的高效率和準確性使該技術比基於培養的鑒定等傳統診斷選項更受青睞。這些特徵正在推動核酸增幅檢查技術的發展。

COVID-19 增加了對快速、準確的檢測方法的需求，包括核酸增幅檢查，以檢測 SARS-CoV-2 病毒。該市場的主要參與者開發了新產品，例如基於恒溫核酸增幅技術的測試，以滿足快速即時測試的高需求。

例如，2020 年 3 月，雅培實驗室的雅培 ID NOW COVID-19 檢測獲得了緊急使用核准(EUA)，可在 5 分鐘內提供陽性結果，並在 13 分鐘內提供陰性結果。這些由疫情推動的策略舉措預計將在不久的將來推動市場成長。

核酸增幅檢查市場報告亮點

  • 聚合酶鍊式反應（PCR）檢測在2022年佔據最大佔有率，為66.7%，因為它是一種由於其高精度和多重功能而能夠檢測多種病原體的檢測類型。
  • 依用途分，感染疾病佔比最大，2022年為46.4%。全球日益流行的感染疾病以及核酸擴增技術提供的高效檢測方案正在推動這一領域的發展。
  • 北美地區佔比最大，2022年為37.1%。這是因為該地區擁有成熟的醫療保健部門和雅培實驗室 (Abbott Laboratories)、Illumina, Inc. 和 Bio-Rad Laboratories, Inc. 等主要參與者。
  • 由於醫療保健投資的增加和早期疾病診斷中擴大採用核酸增幅檢查，中心實驗室和標準實驗室最終用途用途市場在 2022 年佔據了 41.9%的市場佔有率。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 核酸增幅檢查市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 核酸增幅檢查市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 核酸增幅檢查：依類型估計與趨勢分析

  • 核酸增幅檢查市場：要點
  • 核酸增幅檢查市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 聚合酶連鎖反應（PCR）測試
  • 恒溫核酸增幅技術（INAAT）測試
  • 連接酶鏈反應（LCR）測試

第5章 核酸增幅檢查：依用途進行估算與趨勢分析

  • 核酸增幅檢查市場：要點
  • 核酸增幅檢查市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 傳染病檢查
  • 腫瘤學測試
  • 遺傳和粒線體疾病檢測

第6章 核酸擴增試驗：依最終用途進行估算與趨勢分析

  • 核酸增幅檢查市場：要點
  • 核酸增幅檢查市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
  • 中央與參考實驗室
  • 其他

第7章 核酸增幅檢查市場：區域估計與趨勢分析

  • 區域預測
  • 按地區分類的核酸增幅檢查市場：要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • F. Hoffmann-La Roche Ltd
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Abbott Laboratories
    • Illumina, Inc.
    • Siemens Healthineers
    • bioMerieux SA
    • Novartis AG
    • Bio-Rad Laboratories, Inc.
    • Seegene Inc.
Product Code: GVR-1-68038-388-1

Nucleic Acid Amplification Testing Market Growth & Trends:

The global nucleic acid amplification testing market size is expected to reach USD 19.2 billion by 2030, registering a CAGR of 12.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising awareness regarding early detection of chronic and infectious diseases, and emerging technological advancements in PCR technology are the factors expected to significantly drive the market growth. In addition, the global rise in the prevalence of infectious diseases such as influenza, hepatitis, and sexually transmitted infections is anticipated to increase the demand for nucleic acid amplification testing and positively affect market growth.

Nucleic acid amplification testing has witnessed a high amount of investment in recent years due to its applicability to diagnose a variety of disease conditions, including life-threatening conditions such as cancer. For instance, the development of Cepheid's Gene Xpert technology involved a total public investment of over USD 252.0 million, including grants of more than USD 56.0 million from the National Institutes of Health, and around USD 73.0 million from other U.S. government departments.

Moreover, the high efficiency and accuracy of nucleic acid amplification testing have led to an increasing preference for the technique over traditional diagnostic options, such as culture-based identification. These attributes are boosting the growth of nucleic acid amplification testing technologies.

COVID-19 has increased demand for rapid and accurate testing methods, including nucleic acid amplification testing, for the detection of the SARS-CoV-2 virus. Key players involved in the market have developed new product offerings, such as isothermal nucleic acid amplification technology-based tests, to meet the high demand for rapid and point-of-care testing.

For instance, in March 2020, Abbott Laboratories received Emergency Use Authorization (EUA) for its Abbott ID NOW COVID-19 test which can deliver positive results within five minutes and negative results within 13 minutes. Such strategic initiatives fueled by the pandemic are expected to boost market growth in the near future.

Nucleic Acid Amplification Testing Market Report Highlights:

  • Polymerase Chain Reaction (PCR) tests held the largest share of 66.7% in 2022 as the testing type allows for the high accuracy and multiplexing capabilities for the detection of a broad range of pathogens
  • By application, infectious diseases accounted for the largest share of 46.4% in 2022. The rising prevalence of the infectious disease globally and efficient testing alternatives offered by nucleic acid amplification techniques are driving the segment
  • North America held the largest share of 37.1% in 2022, due to the presence of an established healthcare sector and key players such as Abbott Laboratories; Illumina, Inc.; Bio-Rad Laboratories, Inc., and others in the region
  • Central and reference laboratories end-use segment dominated the market in 2022 with a market share of 41.9% in 2022 due to the increasing healthcare investments and rising adoption of nucleic acid amplification tests for early disease diagnosis

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Nucleic Acid Amplification Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Nucleic Acid Amplification Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Nucleic Acid Amplification Testing: Type Estimates & Trend Analysis

  • 4.1. Nucleic Acid Amplification Testing Market: Key Takeaways
  • 4.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Polymerase Chain Reaction (PCR) Tests
    • 4.3.1. Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    • 4.4.1. Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Ligase Chain Reaction (LCR) Tests
    • 4.5.1. Ligase Chain Reaction (LCR) Tests market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis

  • 5.1. Nucleic Acid Amplification Testing Market: Key Takeaways
  • 5.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Infectious Disease Testing
    • 5.3.1. Infectious disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2. Covid-19 Testing
      • 5.3.2.1. Covid-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.3. Mosquito Borne Disease Testing
      • 5.3.3.1. Mosquito borne disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.4. Influenza Testing
      • 5.3.4.1. Influenza testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.5. Sexually Transmitted Infectious Testing
      • 5.3.5.1. Sexually transmitted infectious testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.6. Hepatitis Testing
      • 5.3.6.1. Hepatitis testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.7. Tuberculosis Testing
      • 5.3.7.1. Tuberculosis testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.8. Others
      • 5.3.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Oncology Testing
    • 5.4.1. Oncology testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Genetic & Mitochondrial Disease Testing
    • 5.5.1. Genetic & mitochondrial disease testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Nucleic Acid Amplification Testing: End Use Estimates & Trend Analysis

  • 6.1. Nucleic Acid Amplification Testing Market: Key Takeaways
  • 6.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Central and Reference Laboratories
    • 6.4.1. Central and reference Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Nucleic Acid Amplification Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Nucleic Acid Amplification Testing Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. F. Hoffmann-La Roche Ltd
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Becton, Dickinson and Company
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Danaher Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Abbott Laboratories
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Illumina, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Siemens Healthineers
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. bioMerieux SA
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novartis AG
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Bio-Rad Laboratories, Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Seegene Inc.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 France nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 48 China nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 India nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Thailand nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Nucleic acid amplification testing: Market outlook
  • Fig. 9 Nucleic acid amplification testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Nucleic acid amplification testing market driver impact
  • Fig. 15 Nucleic acid amplification testing market restraint impact
  • Fig. 16 Nucleic acid amplification testing market strategic initiatives analysis
  • Fig. 17 Nucleic acid amplification testing market: Type movement analysis
  • Fig. 18 Nucleic acid amplification testing market: Type outlook and key takeaways
  • Fig. 19 Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 - 2030
  • Fig. 20 Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 - 2030
  • Fig. 21 Ligase chain reaction (LCR) tests market estimates and forecasts, 2018 - 2030
  • Fig. 22 Nucleic acid amplification testing market: Application movement analysis
  • Fig. 23 Nucleic acid amplification testing market: Application outlook and key takeaways
  • Fig. 24 Infectious disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 25 Covid-19 testing market estimates and forecasts, 2018 - 2030
  • Fig. 26 Mosquito borne disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 27 Influenza testing market estimates and forecasts, 2018 - 2030
  • Fig. 28 Sexually transmitted infection testing market estimates and forecasts, 2018 - 2030
  • Fig. 29 Hepatitis testing market estimates and forecasts, 2018 - 2030
  • Fig. 30 Tuberculosis testing market estimates and forecasts, 2018 - 2030
  • Fig. 31 Others testing market estimates and forecasts, 2018 - 2030
  • Fig. 32 Oncology testing market estimates and forecasts, 2018 - 2030
  • Fig. 33 Genetic & mitochondrial disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 34 Others testing market estimates and forecasts, 2018 - 2030
  • Fig. 35 Nucleic acid amplification testing market: End-use movement analysis
  • Fig. 36 Nucleic acid amplification testing market: End-use outlook and key takeaways
  • Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 38 Central and reference laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030
  • Fig. 40 Global nucleic acid amplification testing market: Regional movement analysis
  • Fig. 41 Global nucleic acid amplification testing market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 48 France market estimates and forecasts, 2018 - 2030
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 India market estimates and forecasts, 2018 - 2030
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030